From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Can ß-Blockers Prevent Gastroesophageal Varices?

Although nonselective beta-blockers reduce the incidence of bleeding in patients with cirrhosis who already have varices, they failed to prevent varices from developing in this randomized trial.

Nonselective ß-blockers reduce the incidence of bleeding in patients with cirrhosis who have gastroesophageal varices. However, whether ß-blockers can prevent the development of varices is unclear.

In this randomized trial, researchers enrolled 213 patients with cirrhosis and portal hypertension (i.e., hepatic venous pressure gradient [HVPG] ≥6 mm Hg), but with no endoscopic evidence of gastroesophageal varices. Patients received either the nonselective ß-blocker timolol (dosed to reduce heart rate by 25% or to <55 beats/min) or placebo, and underwent repeat endoscopy yearly. During a median follow-up of 55 months, the proportions of patients who developed varices or variceal bleeding were virtually identical in the timolol and placebo groups (39% vs. 40%). Frequencies of secondary endpoints (e.g., death, ascites, encephalopathy) were also similar in the two groups. Adverse events rated as serious occurred significantly more often in the timolol group (18% vs. 6%).

Development of varices or variceal bleeding correlated with baseline HVPG and with changes in HVPG over time. Although timolol did reduce the average HVPG more than placebo did, the difference did not reach statistical significance.

Comment: In this study, a nonselective ß-blocker did not prevent varices; for now, clinicians should not prescribe ß-blockers for this purpose. However, the results imply that more effective and safer agents to lower the hepatic venous pressure gradient might well prevent the development of varices.

— Allan S. Brett, MD

Published in Journal Watch General Medicine December 9, 2005

Citation(s):

Groszmann RJ et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005 Nov 24; 353:2254-61.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.